I hold a portfolio that follows your BEPORT with a few of my own thrown in.
I hold 1/2 weights of XTC and AEM, and was thinking of topping them up with some added cash that I have.
Would you be comfortable adding to these for long term hold at this time. In particular I am concerned about XTC with U.S. sentiments.
Q: I am planning to own all stocks in growth, income and model portfolio excluding ETF.
I would allocated Growth = 1%, Income = 1.75% and Model = 2.25%
Do you think this is the good strategy and it will work going forward?
Total stocks = 59.
I set up dummy portfolio since Nov 2016 and it has the gain of 11%.
Currently, I own all stocks in Model portfolio with 3% waiting and it has gain 6%
Q: 2 questions on GUD:
* Recent report states " GUD also invests in funds, which have substantial assets under management in the healthcare sector..." What type of funds, private equity or mutual, and how major is this part of their business?
* Your models have 3 and 6% positions in this name, my weight is 2.5% and I'm wondering what is a suitable number, though I would be comfortable up to 5%. I am retired and it is presently my only health care stock.
Thanks, J.
Q: Prometic announced a small ($9.5 million) purchase order from an existing client last Friday, and they seem primed for several growth opportunities/catalysts in 2017. Yet the share price keeps dropping.
Would you be on board with an initial purchase at this time? Or wait for more good news?
Thank you.
Q: CRH has lots of momentum currently. I am starting to get concerned about P/E ratios. What is the P/E to growth ratio, and please give some comments on the company\s ability to grow earning to meet this ratio.
Q: Hi, Peter could please provide your view on this co. Long term. Should I buy in rrsp or t f a c acct? I would like to buy 7-8 % for one and 5-6% of the other. Thanks for your help .
Q: Hi there, I am an investor in my early 30's and follow your Balanced Equity portfolio and understand that it is an excellent mix of growth and stability names. I am curious to know what adjustments you would make if I were looking to substitute the more stable, less risky names with names with higher growth torque - names similar to KXS, NFI, PBH, SIS etc (so maybe not as small and volatile as some names in the Growth portfolio). Thanks for your awesome service!
Q: Hi,
I have these 4 companies in my portfolio. I try to copy your balanced equity portfolio as much as possible which is why I have ENB, MX and WCP. I added SPB last year on one of your suggestions and I'm up 46% on it.
Do I have too many in this sector and should I sell them, keep them or do you have a better company to replace it with?
Q: How material is the announcement of a settlement in the dispute over intellectual property (Photon Control Announces Completion of Settlement Agreement with Photon R&D [source: CW]) to the medium-term prospects for PHO?
This has been a long-term, ultimately successful, investment for me which I started buying in 2006 for an average price of $0.18, so volatility is not a big concern.
Q: Currently have no materials stocks. In the recent past I have owned cco, teck.b and hbm but as short term holds on weakness/momentum. Looking to add a longterm hold in materials but I am having trouble falling in love with SJ mainly due to the past 12 month stock, relatively low div of 1% and the general high for the sector PE of 18. CCL isn't a classic "materials" stock although I like the look of the price movement.
Can you make your case for me to jump on the SJ and CCL 5i bandwagon and/or suggest a few other options.
Working on matching the balanced equity portfolio.
Q: As a new member, I am puzzled by the composition of the Coverage Summary spreadsheet and accompanying 70-company report database. Perhaps I am missing something, but it seems to me that the research database would be more useful to an investor if it contained 70 companies all of which are highly rated. I don't understand the rationale for including companies that are rated lower than B. There must be more Canadian companies that would fall into the A or B categories. It also puzzles me that many of the companies in the model portfolios are not covered by the research.
In summary, would it be possible to include some notes on the website or accompanying the spreadsheet/database explaining how the 70 companies were chosen, how this research is to be used by an investor, and how and when companies are added or removed from the coverage.
Q: I am retired. I have a small locked-in RIF (100k) and I will start to withdraw the maximum amount permitted this year. So far, the money was invested in 3 Gics of an equal amount. That approach suited me when the interest rates were higher . But, since the interest rates remain low it does not work anymore.
I need a higher return and i want to protect the capital and keep things simple.
I am willing to put 50% in fix income and 50% in equity with dividends.
1) what will be the most efficient way to invest that money?
2) For the fix income ,should I use monthly income fund like Pimco or Sentry NCE 1032?
3) Which Etf or fund can I use for the equity portion and in which proportion?
The balanced portfolio was launched in March. In your report, does the annual return refers to the calender year or the 12-month period ending on March of each year?
Q: Internal discussions at my end!! What is the current Price to Book (I calculate - just over 10. Also I figure the P/E ratio about 60. Do you agree? Thank you.
Q: Sorry for asking another question about SYZ, but something doesn't smell right here. It appears that a couple executives bought some small amounts of stocks (aprox $250K) late last year, which for a light trading stock like this creates some excitement and pushes the stock higher and then late January the CEO and and officer sold $7.1 millions worth of stock, just before a bad quarter and the stock drops like a rock. While maybe legal, it doesn't feel right to say the least and I don't understand how the sale went through as it trades very lightly.
Do you have any concerns about management practices? Does it point to deeper problems at the company?